Samarth Kulkarni - 14 Mar 2025 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRSP	Stock Option (Right to Buy)	Award	$0	+110,000		$0.000000	110,000	14 Mar 2025	Common Shares	110,000	$42.12	Direct	F1
transaction	CRSP	Restricted Stock Units	Award	$0	+82,500		$0.000000	82,500	14 Mar 2025	Common Shares	82,500		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This option was granted on March 14, 2025 with respect to 110,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 14, 2025.
F2	Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
F3	This restricted stock unit award was granted on March 14, 2025 with respect to 82,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029.